Oric Pharmaceuticals, Inc. ORIC Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $116.62M-0.1% | $109.82M-3.7% | $115.93M+8.8% | $118.36M+21.1% | $116.75M+33.3% | ||
| $33.29M+11.4% | $33.19M+15.1% | $32.09M+13.9% | $31.31M+14.5% | $29.87M+12.8% | ||
| $149.91M+2.2% | $143M+0.1% | $148.02M+9.8% | $149.67M+19.6% | $146.62M+28.5% | ||
| -$149.91M-2.2% | -$143M-0.1% | -$148.02M-9.8% | -$149.67M-19.6% | -$146.62M-28.5% | ||
| $14.69M+6.7% | $13.54M-10.0% | $12.75M-14.3% | $12.42M-13.4% | $13.77M+11.7% | ||
| -$135.21M-1.8% | -$129.47M-1.3% | -$135.27M-12.8% | -$137.25M-23.9% | -$132.86M-30.6% | ||
| -$1.41+24.6% | -$1.49+18.1% | -$1.73+4.4% | -$1.89-7.4% | -$1.87-3.3% | ||
| -$148.72M-2.2% | -$141.78M0.0% | -$146.82M-9.8% | -$148.48M-19.7% | -$145.48M-28.7% | ||
| -$149.91M-2.2% | -$143M-0.1% | -$148.02M-9.8% | -$149.67M-19.6% | -$146.62M-28.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Oric Pharmaceuticals, Inc. profitable?
- Oric Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $135.2M over the trailing twelve months.
- What is Oric Pharmaceuticals, Inc.'s earnings per share?
- Oric Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-1.41.
- Where does Oric Pharmaceuticals, Inc.'s income statement data come from?
- Every line is extracted from Oric Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.